According to Canada's Companies' Creditors Arrangement Act (CCAA), and for which BioAmber's insolvency case is currently filed under, CCAA defines "equity claim" separately and distinct from "equity interest":
In the Supplementary Report of the Seventh Report of the Monitor, Marc Duchesne, the attorney for PwC (Borden Ladner Gervais, LLP), responded to the "Crane Letter" with the following statement:
Again, PwC has maintained their expertise in what they do not say, specifically as it relates to equity interest.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.